The results indicated that while both siRNAs effectively reduced STAT3 expression, SiRNA 2 exhibited a more pronounced knockdown effect, leading to greater suppression of glioblastoma cell proliferation (Figure 5). The gene discussed is STAT3; the disease is glioblastoma.